Notification That Annual Report Will Be Submitted Late (nt 10-k)
January 31 2022 - 4:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
SEC
File Number:
000-55008
NOTIFICATION
OF LATE FILING
(Check
One):
|
☒
Form 10-K ☐ Form 20-F ☐ Form 11-K
☐ Form 10-Q ☐ Form 10-D ☐
Form N-SAR ☐ Form N-CSR
|
For
Period Ended: October 31, 2021
☐
Transition Report on Form 10-K
☐
Transition Report on Form 20-F
☐
Transition Report on Form 11-K
☐
Transition Report on Form 10-Q
☐
Transition Report on Form N-SAR
For
the Transition Period Ended: ________________________
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART
I -- REGISTRANT INFORMATION
ORGANICELL
REGENERATIVE MEDICINE, INC.
Full
Name of Registrant
____________________________
Former
Name if Applicable
4045
Sheridan Ave, Suite 239
Address
of Principal Executive Office (Street and Number)
Miami,
Florida 33140
City,
State and Zip Code
PART
II -- RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate.)
|
(a)
|
The reasons
described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
☒
|
(b)
|
The subject annual report,
semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
|
|
|
|
|
(c)
|
The accountant's statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III-- NARRATIVE
State
below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not
be filed within the prescribed time period. (Attach extra sheets if needed.)
The
compilation, dissemination and review of the information required to be presented in the Annual Report on Form 10-K for the year ended
October 31, 2021 could not be completed and filed by January 31, 2022, without undue hardship and expense to the registrant. The registrant
anticipates that it will file its Annual Report on Form 10-K for the year ended October 31, 2021 within the applicable “grace”
period provided by Securities Exchange Act Rule 12b-25.
PART
IV -- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification
Ian
Bothwell
|
|
310
|
|
200-9741
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s).
☒ Yes ☐ No
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
☐ Yes
☒ No
If
so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
Health-Right
Discoveries, Inc.
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date: January
31, 2022
|
By:
|
/s/
Ian Bothwell
|
|
|
Ian Bothwell,
|
|
|
Chief Financial Officer
|